Trial Profile

A phase 2 clinical trial of CDX-7108

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 01 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CDX-7108 (Primary)
Indications Exocrine pancreatic insufficiency; Gastrointestinal disorders
Focus Therapeutic Use

Most Recent Events

01 Mar 2023 New trial record
23 Feb 2023 According to a Codexis media release, company and Nestle Health Science expect to file an Investigational New Drug (IND) application for this study by the end of 2023.
23 Feb 2023 According to a Codexis media release, company plan to start this study in early 2024 and expected to be conducted over approximately 12 months, with topline data expected in 2025

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com